Benitec Biopharma Inc.

FY: Jun 30 2026

Q: Mar 31 2026

FY: Jun 30 2025

Q: Dec 31 2025

Q: Sep 30 2025

FY: Jun 30 2025

Q: Mar 31 2025

Q: Dec 31 2024

Q: Sep 30 2024

FY: Jun 30 2024

Q: Mar 31 2024

Q: Dec 31 2023

Q: Sep 30 2023

FY: Jun 30 2023

Q: Mar 31 2023

Q: Dec 31 2022

Q: Sep 30 2022

FY: Jun 30 2022

Q: Mar 31 2022

Q: Dec 31 2021

Regulation FD Disclosure

Changes in Registrant's Certifying Accountant

Changes in Registrant's Certifying Accountant

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Regulation FD Disclosure

Results of Operations and Financial Condition

Other Events

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Regulation FD Disclosure

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

BUCHI J KEVIN

Friedman David Matthew

Friedman David Matthew

FRANKLIN RESOURCES INC

Mates Sharon

SUVRETTA CAPITAL MANAGEMENT, LLC; Cowen Aaron; Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.

SUVRETTA CAPITAL MANAGEMENT, LLC; Cowen Aaron; Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.

JANUS HENDERSON GROUP PLC

Mehta Kishan

Mates Sharon

BUCHI J KEVIN

Francis Peter

RA CAPITAL MANAGEMENT, L.P.

Smith Edward F

Banks Jerel A.

Mukadam Sophie

Boston Megan

SUVRETTA CAPITAL MANAGEMENT, LLC; Cowen Aaron; Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.

SUVRETTA CAPITAL MANAGEMENT, LLC

Mates Sharon

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC